Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CCKBR | P32239 | 2/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17830794 | 0.88 | CCKBR (0.38) | ALDH1A1KDM4EHPGDCCKBRMAPT | |
| SCHEMBL17830797 | 0.84 | ALDH1A1 (0.37) | ALDH1A1KDM4E | |
| SCHEMBL17830799 | 0.84 | ALDH1A1 (0.35) | ALDH1A1KDM4EHPGDCCKBRTSHR | |
| SCHEMBL17830801 | 0.83 | HSP90AA1 (0.37) | ALDH1A1MEN1KMT2ACCKBRMAPT | |
| SCHEMBL17830708 | 0.82 | CACNA1B (0.47) | MEN1KMT2AUSP2POLB | |
| SCHEMBL17830798 | 0.81 | MEN1 (0.37) | ALDH1A1MEN1KMT2AKDM4EHPGD | |
| SCHEMBL17830802 | 0.81 | MDM2 (0.34) | ALDH1A1KDM4ECCKBRTSHR | |
| SCHEMBL17830803 | 0.79 | PTPN7 (0.35) | ALDH1A1KDM4EPOLB | |
| SCHEMBL17830796 | 0.79 | ALDH1A1 (0.37) | ALDH1A1MEN1KMT2AMAPTTSHR | |
| SCHEMBL17830793 | 0.79 | PARK7 (0.37) | ALDH1A1MEN1KMT2AHPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160166549-A1 | BCL6 INHIBITORS AS ANTICANCER AGENTS | CORNELL UNIVERSITY | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160166549-A1 | BCL6 INHIBITORS AS ANTICANCER AGENTS | BCL6, BCL6B, BAZ2A | ALDH1A1 4832/4885MEN1 3321/4885KMT2A 1188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.